PharMerica (PMC) Raises FY14 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Goldman Sachs Starts PharMerica (PMC) at Neutral
September 11, 2014 6:52 AM EDTGoldman Sachs initiated coverage on PharMerica (NYSE: PMC) with a Neutral rating and a price target of $29.00.
Analyst Stephan Stewart said, "We are encouraged by PMCs efforts in managing through the loss of its top two clients (15-20% of sales) with (1) organic underlying... More
